Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.02 - $21.0 $196,478 - $242,424
-11,544 Reduced 18.7%
50,186 $915,000
Q1 2024

May 13, 2024

BUY
$20.45 - $26.49 $1.26 Million - $1.64 Million
61,730 New
61,730 $1.33 Million
Q1 2022

May 13, 2022

SELL
$34.38 - $65.77 $5.22 Million - $9.99 Million
-151,965 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$63.78 - $97.86 $4.87 Million - $7.47 Million
-76,322 Reduced 33.43%
151,965 $10.7 Million
Q3 2021

Nov 15, 2021

SELL
$45.58 - $88.24 $191,208 - $370,166
-4,195 Reduced 1.8%
228,287 $36.4 Million
Q2 2021

Aug 16, 2021

BUY
$34.4 - $48.34 $5.66 Million - $7.96 Million
164,672 Added 242.84%
232,482 $22 Million
Q1 2021

May 14, 2021

BUY
$23.17 - $38.3 $1.57 Million - $2.6 Million
67,810 New
67,810 $4.91 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.42B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.